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EIU in the Rat Promotes the Potential of Syngeneic
Retinal Cells Injected into the Vitreous Cavity
to Induce PVR
Francine F. Behar–Cohen,1,2 Brigitte Thillaye–Goldenberg,2 The´re`se de Bizemont,2
Michelle Savoldelli,1 Dominique Chauvaud,1,2 and Yvonne de Kozak2
PURPOSE. To determine whether syngeneic retinal cells injected in the vitreous cavity of the rat are
able to initiate a proliferative process and whether the ocular inflammation induced in rats by
lipopolysaccharide (LPS) promotes this proliferative vitreoretinopathy (PVR).
METHODS. Primary cultured differentiated retinal Mu¨ller glial (RMG) and retinal pigmented epithelial
(RPE) cells isolated from 8 to 12 postnatal Lewis rats were injected into the vitreous cavity of 8- to
10-week-old Lewis rats (105 cells/eye in 2 ml sterile saline), with or without the systemic injection
of 150 mg LPS to cause endotoxin-induced uveitis (EIU). Control groups received an intravitreal
injection of 2 ml saline. At 5, 15, and 28 days after cell injections, PVR was clinically quantified, and
immunohistochemistry for OX42, ED1, vimentin (VIM), glial fibrillary acidic protein (GFAP), and
cytokeratin was performed.
RESULTS. The injection of RMG cells, alone or in combination with RPE cells, induced the preretinal
proliferation of a GFAP-positive tissue, that was enhanced by the systemic injection of LPS. Indeed,
when EIU was induced at the time of RMG cell injection into the vitreous cavity, the proliferation
led to retinal folds and localized tractional detachments. In contrast, PVR enhanced the infiltration
of inflammatory cells in the anterior segment of the eye.
CONCLUSIONS. In the rat, syngeneic retinal cells of glial origin induce PVR that is enhanced by the
coinduction of EIU. In return, vitreoretinal glial proliferation enhanced the intensity and duration
of EIU. (Invest Ophthalmol Vis Sci. 2000;41:3915–3924)
Proliferative vitreoretinopathy (PVR) remains the majorcause of failure in the surgical treatment of retinal de-tachment. It results from the migration and proliferation
of cells of different origins, among which retinal pigment
epithelial (RPE) cells and retinal Mu¨ller glial (RMG) cells play an
important role. These cells undergo fibroblastic transdifferen-
tiation to form fibrocellular membranes onto both surfaces of
the neuroretina. This is followed by contraction of the cellular
membranes, extracellular collagen production, and formation
of fixed folds of the retina.1–5 Because the very early phases of
PVR do not have a clinical expression in humans, the different
cell types that may be involved in the process and the extent of
the blood–retinal barrier breakdown are difficult to study.6 At
the time when membranes can be dissected for immunohisto-
chemical studies, cells have partially lost their differentiation
characteristics, and the inflammatory mediators could be dif-
ferent from those expressed in the early phases of PVR. Inflam-
mation that increases the release of chemotactic and mitogenic
factors stimulates the proliferation.7 Inflammatory cytokines
are involved in PVR models in rabbits,8 and interleukin (IL)-6,
tumor necrosis factor (TNF), interferon (IFN)-g, and, to a lesser
extent, IL-1a and -1b9 have been identified in epiretinal mem-
branes from human eyes with PVR. Moreover, products of
oxidative reactions, probably originating from activated phago-
cytes and RPE cells, have been detected in the vitreous of
patients operated on for PVR.10 The role of IL-1b has been
experimentally demonstrated in the development of epiretinal
membranes in the presence of retinal holes. Indeed, IL1-b
induces aberrant extracellular matrix remodeling that results in
the proliferative process.11 Cultured human RPE cells consti-
tutionally express cytokines, such as IL-1, IL-6, IL-8, and trans-
forming growth factor (TGF)-b, that are upregulated when the
cells are exposed to a medium of lipopolysaccharide (LPS)-
stimulated monocytes. This shows that activated monocytes
present when the external hematoretinal barrier is disrupted,
produce stimulating factors, among which IL-1 and TNF seem
to be the more potent in inducing cytokine expression in
human RPE cells in vitro.12
Endotoxin-induced uveitis (EIU) in the rat is a model of
self-limited inflammation involving both the anterior and the
posterior segment of the eye.13–15 Cytokines such as IL-1, IL-6,
IL-8, TNFa, and IFNg, synthesized both by activated resident
cells and infiltrating cells, are implicated in the inflammatory
cascade of events taking place in EIU.16–19 The inducible nitric
oxide synthase (NOSII) is also expressed during EIU in infil-
trating cells and RMG cells,19,20 and analogues of arginine more
specific for the NOSII isoform have an anti-inflammatory ef-
fect.21–23 In the present study, we injected syngeneic differen-
tiated RPE and/or RMG cells in the vitreous of rat eyes with EIU
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to answer the following questions: Do syngeneic RPE or RMG
cells injected separately into the vitreous cavity initiate a pro-
liferative process, or do they have to be injected in combina-
tion? Does the ocular inflammation induced in rats by LPS
promote the proliferation of syngeneic RPE and/or RMG cells
injected into the vitreous cavity?
MATERIALS AND METHODS
Preparation of Retinal Resident Cells
RPE and RMG cells were isolated from Lewis rat retinas on
postnatal days 8 through 12, by a method previously de-
scribed.24 Briefly, eyeballs from decerebrated young rats were
incubated in Dulbecco-modified Eagle’s medium (DMEM) con-
taining 0.2% trypsin (Difco, Detroit, MI) and 100 U/ml collage-
nase type CS-1 (Worthington, Freehold, NJ). For RMG cells, the
neural retinas were separated from the lens and vitreous, cut
into small fragments, and plated in 100-mm petri dishes in
DMEM containing 10% fetal calf serum (FCS). After 3 to 4 days,
fragments were removed by extensive rinsing with phosphate-
buffered saline (PBS), and the remaining flat cell population
(mainly RMG cells)24 were refed with DMEM. RMG cells grew
rapidly. For RPE cells, pigment epithelium sheets were gently
dissociated after rinsing with PBS containing 0.02% EDTA and
0.05% trypsin and the cells seeded as dispersed suspensions in
DMEM containing 10% FCS. The purity of cultures was con-
trolled by immunocytochemical staining.24 Briefly, cells on
coverslips were incubated with the following antibodies: poly-
clonal antibody anti-CRALBP, a marker specific for RPE cells;
polyclonal antibody anti-GS, a marker specific for RMG cells;
monoclonal antibody OX42 (antiC3b antigen and a marker for
macrophages subsets including microglia); and polyclonal an-
tibody anti-vWF, a marker for vascular endothelial cells. RMG
and RPE cells were frozen as primary cultures and then were
defrosted and suspended in DMEM, centrifuged at 1000 rpm
for 10 minutes, and injected into the vitreous at a concentra-
tion of 105 cells in 2 ml in sterile pyrogen-free 0.9% NaCl. Cell
viability was controlled by trypan blue counting before injec-
tion. After defrosting, an average of 17% of RMG cells and 20%
of RPE cells observed were dead.
Dead RPE and RMG cells were injected into the vitreous
cavity of four eyes of four rats that received a systemic injec-
tion of LPS as a control group. Dead cells were obtained by UV
irradiation, and cell viability was controlled by trypan blue
counting. RMG cells were more resistant to irradiation than
RPE cells. A 15-minute irradiation killed 90% of RPE cells,
whereas a 4-hour irradiation was necessary to kill 90% of the
RMG cells.
Experimental Protocol
Induction of EIU. Inbred Lewis rats, 8 to 10 weeks old
(Pierre Ravaut, Institut National de la Recherche Agronomique,
Nouzilly, France) were injected in the right foot pad with LPS
from Salmonella typhimurium (Sigma, St. Louis, MO) at 150
mg per rat in a volume of 150 ml sterile pyrogen-free sa-
line.13,25,26 The experiments were conducted in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research.
Intravitreal Injection of Retinal Cells. Before intravit-
real injection, rats were anesthetized with intraperitoneal in-
jection of pentobarbital (40 mg/kg Nembutal; Abbot, Saint-
Remy sur Avre, France), and the pupil was dilated with 1 drop
of tropicamide (Mydriaticum; Chibret, Clermont Ferrand,
France). Injections (2 ml) were performed using a sterile Ham-
ilton syringe (Poly-Labo, Paris, France) and 30-gauge disposable
needles (Microlance3; Becton Dickinson, Madrid, Spain) under
an operating microscope. A coverslip was adapted on the
corneal surface to control the fundus during the injection.
Pictures of the fundus were obtained by using a retinograph for
small animals (Kowa Genesis; Luneau, Chartres, France) imme-
diately after the cell injections. Any bleeding or a lens touch
observed at the end of the injection excluded the rat from the
protocol.
Rats (four eyes per group) received injections of RPE cells,
RMG cells, a mixture of RPE and RMG cells (RPE1RMG; 105
cells in 2 ml sterile pyrogen-free saline 0.9%), or saline. These
four types of intravitreal injections were administered to rats
that were or were not stimulated by the systemic injection of
LPS at the time of the ocular injections. Therefore, one group
of rats received both the intravitreal injections and the sys-
temic injection of LPS, whereas the other received only the
intravitreal injections.
To study the early stages of proliferation, eight rats with
eyes injected with RPE1RMG and stimulated with LPS were
killed at day 5 and excised eyes examined by either classic
histology (four eyes) or immunohistochemistry (four eyes). At
further stages (15 and 28 days) EIU-affected animals (four eyes
per group) injected with RPE, RMG, RPE1RMG, or saline were
killed for immunohistochemistry.
Follow-up
Clinical Observation. Animals were examined daily by
biomicroscopy and indirect ophthalmoscopy. Retinophoto-
graphs were taken after the injection and at 5, 15, and 28 days.
The proliferative response was evaluated according to the
following grade scale, as shown on fundus pictures in Figure 1:
0, no proliferative response; 1, intravitreal proliferation; 2,
preretinal membrane formation with retinal folds; 3, white
dense membrane covering the retina with retinal folds, local-
ized retinal detachments, with or without localized posterior
capsular cataract. After the injection of the cells, a vitreal
Tyndall effect was observed in the entire vitreous cavity, sug-
gesting that the injected cells spread throughout the vitreous
cavity and did not stay at the injection site, as was described
with injections in the rabbit vitreous.
In one experiment, at 15 days after the injection into the
vitreous of the different cell types, the eyes (four per group)
were enucleated for dissection under a binocular microscope.
The ocular globes were cut pre-equatorially and photographed
to show the gross aspect of the retina in situ (Fig. 3).
To assess the severity of uveitis, rats were examined at 24
hours and 4 and 6 days after LPS injection. The severity of EIU
was graded from 0 to 4 by a masked investigator as follows: 0,
no inflammatory reaction; 1, discrete dilation of the iris and
conjunctival vessels; 2, moderate dilation of the iris and con-
junctival vessels; 3, intense iridal hyperemia with flare in the
anterior chamber; 4, same clinical signs as grade 3 plus the
presence of fibrinous exudate in the pupillary area with intense
flare in the anterior chamber.20 The EIU grade of rats injected
in the vitreous with RMG or saline was compared using the
nonparametric Mann–Whitney test.
3916 Behar–Cohen et al. IOVS, November 2000, Vol. 41, No. 12
Histopathologic Examination. At the time of death, 5,
15, and 28 days after the cell injections with or without sys-
temic LPS injection, rats were anesthetized with pentobarbital
(40 mg/kg Nembutal, Abbot) and perfused with 2% parafor-
maldehyde. Eyes were enucleated and postfixed for 1 hour in
2% paraformaldehyde at room temperature, rinsed in 5% su-
crose for 5 hours at 4°C, and then incised in the sclera,
incubated overnight in 15% sucrose at 4°C, and stored at
220°C. The eyes were then included in optimal cutting tem-
perature (OCT; Tissue-Tek; Miles, Elkhart, IN) and 10-mm fro-
zen sections were mounted on gelatin-covered slides to per-
form immunohistochemical analysis.
Immunohistochemistry
OX-42 and ED1. OX-42 antibody (anti-C3b receptor) was
used as a marker for microglia, activated macrophages, den-
dritic cells, and polymorphonuclear leukocytes and ED1 anti-
body as a marker for monocytes, macrophages, and some
dendritic subpopulations.14 Sections were washed with PBS,
rinsed, incubated for 1 hour at 37°C with PBS containing 5%
skimmed milk, and then incubated with either monoclonal
OX-42 antibody (anti-C3b receptor) or monoclonal ED1 anti-
body (Serotec, Oxford, UK), each diluted 1:100 in PBS 1%
skimmed milk. After they were washed in PBS, sections were
incubated with biotinylated sheep anti-mouse IgG (1:10 in
PBS-1% skimmed milk) and then with fluorescein isothiocya-
nate (FITC)–conjugated streptavidin (1:100 in PBS-1%
skimmed milk), for 1 hour at room temperature. After another
washing, they were secured with coverslips. Results of control
experiments using rabbit preimmune serum or omitting the
first antibody were negative (data not shown).
GFAP, Vimentin, and Cytokeratin. Mouse monoclonal
anti-vimentin (VIM; Sigma) is a marker of one of the five groups
of cytoskeletal intermediate filaments, and mouse monoclonal
anti-pan epithelial cytokeratin (CytoK; Boehringer–Mannheim,
Mannheim, Germany) is an antibody that reacts with an
epitope common to all cytokeratins,1–19 found in all epithelia.
Proliferating RPE were more specifically identified by the cy-
tokeratin 18 antibody (Zymed, San Francisco CA).27 Each anti-
body was used at a dilution of 1:50 in PBS-1% skimmed milk,
except anti-cytokeratin 18, which was used at 1:10. The rabbit
polyclonal antibody anti-glial fibrillary acidic protein (GFAP;
Dako, Carpinteria, CA), directed at GFAP was used diluted at
1:100. After a washing, sections were incubated for 1 hour
with biotinylated sheep anti-mouse IgG (1:50 in PBS-1%
skimmed milk) or with biotinylated sheep anti-rabbit IgG (1:50
in PBS-1% skimmed milk) and then for 1 hour with fluorescein-
FIGURE 1. Retinophotographies showing the proliferation scale: 0, no proliferative response; 1, intravitreal proliferation; 2, preretinal membrane
formation with retinal folds; and 3, white, dense membrane covering the retina with retinal folds, localized retinal detachments, with or without
localized posterior capsular cataract.
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conjugated streptavidin (1:50 in PBS-1% skimmed milk; Amer-
sham Life Science, Little Chalfont, UK). Sections were ob-
served using a photomicroscope (FXA; Nikon, Tokyo, Japan).
RESULTS
Clinical Examination
EIU Grade. The intravitreal injection of RMG cells en-
hanced and prolonged the severity of EIU. At 24 hours after LPS
injection, the EIU grade of rats that received the intravitreal
injection of RMG cells was 3.12 6 1.25 (n 5 8), compared with
1.12 6 0.35 (n 5 8) for rats that were injected with saline (P 5
0.003). At 4 days after LPS injection, the EIU grade was 2.25 6
0.46 (n 5 8) in the group that received the RMG injection
compared with 1.12 6 0.35 in the group that received saline
(P 5 0.001). At 6 days, the EIU grade was still 2.0 6 0.44 (n 5
6) in the group of rats injected with RMG cells, whereas it was
0.8 6 0.4 (n 5 6) in the saline-injected group (P 5 0.03).
PVR 15 Days after the Injection of Retinal Cells.
Clinically, no anterior inflammation was detected at 15 days in
any eyes injected with RMG or RPE cells, and in the control
group of rats that received only saline injected into the vitreous
cavity with or without LPS, findings in the fundus examination
were normal (Fig. 2A).
In the group of rats that received retinal cells without LPS
stimulation, a limited intravitreal proliferation arising from the
retina could be observed but no retinal detachment (Fig. 2).
Among eyes injected only with RPE cells, two eyes had no
proliferative response, and two eyes had mainly an intravitreal
fibrocellular formation arising from the optic nerve head. On
the contrary, in the eyes injected with RMG cells with or
without RPE cells, the ocular inflammation induced by LPS
enhanced the level of membrane formation. Indeed, prolifera-
tion was observed in 10 of 12 eyes (Fig. 2): A grade 3 PUR was
observed in 3 of 4 eyes when RMG cells were injected alone
and in all eyes when RPE1RMG were injected. At PVR grade 3,
a white, dense neoformed tissue extended into the vitreous
and onto the retinal surface, altering the visibility of the retina
and the retinal vessels, which appeared dilated at the periphery
of the retina (Fig. 1). This aspect was confirmed by the direct
examination of the retina at 15 days after the injection of
RPE1RMG cells and LPS, during the dissection (Fig. 3). Multi-
ple folds and localized detachment were observed, particularly
at the posterior pole (Fig. 3B), in comparison with the retina of
the rat that received only the saline injection (Fig. 3A).
Therefore, the strongest proliferative process was induced
by the injection of RMG or the coinjection of RMG and RPE
cells in EIU-affected eyes.
PVR 28 Days after Injection of Cells. No proliferation
was observed in any eyes that received saline injection in the
vitreous, with or without LPS injection (grade 0; Fig. 2B).
When no EIU was induced, no retinal detachment (grade
3) was ever observed, and no proliferative response (grade 0)
was noted in 4 of 12 injected eyes. When RMG or RMG1RPE
were injected, a limited intravitreal and prepapillary prolifera-
tion of grade 1 or 2 could be observed in 50% of the eyes.
When the injected cells were only RPE, a prepapillary mem-
brane was observed in one eye only. Therefore, RMG seems
more potent than RPE to stimulate an intravitreal and preretinal
proliferation in the normal rat eye.
When EIU was induced, the clinical observation was dif-
ferent. In the eyes that received either RMG alone or the
coinjection of RMG and RPE cells, the progressive intravitreal
and preretinal proliferation led to localized folds and localized
retinal detachments in all cases. In some eyes, the retina could
hardly be examined because of the dense membrane formation
FIGURE 2. Proliferation grade. Re-
sults of clinical examinations at 15
(A) and 28 (B) days after intravitreal
injections.
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developing into the vitreous. Moreover, a localized subcapsular
posterior cataract occasionally appeared (3 of 14 eyes, PVR
grade 4) at a late stage of the proliferation (.15 days). This
cataract seemed to originate from proliferating cells growing
on the anterior retina that invaded the posterior capsule. This
phenomenon was identified when eyes were dissected under a
microscope. When dead RMG1RPE cells were injected into
the vitreous of rats stimulated by systemic injection of LPS, no
clinical or histologic proliferation was observed at any time of
examination (from day 1 to 28; data not shown).
Histologic and Immunohistochemical Analysis of
Eyes 5 Days after RPE1RMG Injections and
Systemic Stimulation with LPS
As shown in Figure 4, at this early time point, there were
already numerous cells at the retinal surface in an extracellular
matrix that could be fibrin and collagen fibrils (Figs. 4A, 4D).
Cells at the retinal surface had established connections with
the inner retina (Fig. 4B), and in some areas true ruptures of
the inner limiting membrane (ILM) could be observed (Fig. 4E).
Numerous cell phenotypes constituting these early membranes
were demonstrated on semithin sections (Fig. 4D) and by
immunohistochemistry. Indeed, at that stage, ED1- (Fig. 4G)
and GFAP-positive cells (Fig. 4F) were found in the vitreous
and over the retinal surface. Pan anti-cytokeratin identified no
RPE over the ILM and in the vitreous but labeled the resident
RPE (Fig. 4H). This finding suggests that injected RPE cells had
probably already undergone apoptosis at that time. Anti-cyto-
keratin 18 antibody confirmed the absence of RPE cells in the
vitreous and labeled the resident RPE, suggesting that they
were in a proliferative state. Giant cells could correspond to
phagocytic macrophages’ having ingested RPE (Fig. 4B). This
finding is currently under investigation in the very early days of
this PVR model.
Immunohistochemical Analysis of Eyes 15 and 28
Days after Injections
At 15 days, in control rats with EIU that had saline injected into
the vitreous, rare ED1-positive (Fig. 5A) and OX42-positive
(Fig. 5B) cells were still present in the iris and ciliary body, and
some OX42-positive cells were found in the retina (Fig. 5E). In
these rats, positive staining of retinal RMG cells with anti-GFAP
and anti-VIM antibodies was observed, but no membrane for-
mation in the vitreous or at the retinal surface (Figs. 5C, 5D). In
control rat eyes that received no injection of cells or LPS, no
anti-GFAP and no anti-VIM staining was observed (results not
shown), suggesting that LPS induced an activation of retinal
glial cells that lasted at least 15 days after the clinical uveitis. In
contrast, in control eyes of animals injected in the footpad with
LPS only, no inflammatory cells could be detected at that time
(data not shown).
When RMG and RPE cells were injected into the vitreous
of rats that did not receive LPS, positive staining of RMG cells
with GFAP and VIM was observed throughout the retina, but
no membrane formation, retinal proliferation, or retinal folds
were observed (not shown). When RMG cells, with or without
RPE cells, were injected into EIU-affected eyes, the number of
OX42- and ED1-positive cells observed in the iris and ciliary
body (Figs. 6A, 6B, 7A, 7B) seemed to be increased compared
with EIU-affected eyes that received only saline intravitreal
injection. The intravitreal injection of retinal cells prolonged
the cell infiltration in the anterior segment of eyes with EIU,
but not in the retina (Fig. 7E compared with 6E).
Immunohistochemistry confirmed the clinical observation
of preretinal proliferation that was positively labeled by anti-
GFAP and anti-VIM glial antibodies (Figs. 6, 7), covering the
whole retinal surface (Figs. 6C, 7C) and causing in some cases
localized retinal detachment (Figs. 7D, 7E, 7F) mostly in the
case of RMG injection. At the ILM level, the GFAP-positive
proliferative process seemed to originate from resident glial
cells that looked disorganized (Fig. 7C).
In rats with EIU that were injected with RMG1RPE, strong
GFAP and VIM positivity was detected in all resident RMG cells
located either in continuity with or at a distance from the
membranes, throughout their length. The vitreal end feet of
RMG cells seemed disorganized. Cytokeratin labeling was
dense in the RPE layer (Figs. 5F, 6F), in comparison with the
staining found in the saline1LPS–injected eyes, suggesting that
the resident RPE cells could have proliferated, even in places
where no retinal detachment was observed (Fig. 6F). At this
time point, the injected cells could no longer be observed in
the vitreous or at the ILM surface. The same observations was
made in the group of rats injected with RMG and RPE cells and
stimulated with LPS. However, in this case, the intravitreal
FIGURE 3. Pictures of the retina in situ during dissection of ocular
globes. (A) Retina of a rat 15 days after systemic injection of LPS and
saline (2 ml) intravitreal injection, showing a normal flat retina. (B)
Retina of a rat 15 days after systemic injection of LPS and RPE1RMG
intravitreal injection, showing a white dense membrane at the retinal
surface. The retina seemed folded, and retinal vessels, only visible at
the periphery, were dilated and tortuous.
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proliferation was so dense in some cases (as shown on direct
examination of the dissected retina (Fig. 3) that it was very
difficult to obtain sections without damaging the retina. In the
eyes in which the retina could be observed, the glial fibrous
membrane on the retinal surface also led to tractional retinal
detachments. The same observations were made at 28 days
after the injections, demonstrating that the proliferative pro-
cess took place rapidly after cell injections and then did not
decrease in the course of time.
DISCUSSION
These experiments were designed to evaluate the effect of the
injection of syngeneic retinal cells of epithelial and glial origin
into the vitreous cavity of rats with an acute ocular inflamma-
tion induced by systemic LPS injection. PVR is thought to be
due to the proliferation and activation of mostly RPE and glial
retinal cells located in the vitreous cavity when a retinal tear
has occurred.7 However, several critical events could play a
FIGURE 4. Histologic and immuno-
histochemical analysis of eyes 5 days
after RPE1RMG injections and sys-
temic stimulation with LPS. (A) His-
tologic section of the retina, showing
a membrane in formation at the reti-
nal surface. (B) Higher magnification,
showing numerous cell phenotypes
and a macrophage ingesting frag-
mented nuclei cells (arrow). (C) Ret-
inal epithelium at a site where multi-
ple layers can be observed growing
on a preserved Bruch membrane (ar-
rows). (D) Semithin section of inner
retina showing a membrane in forma-
tion at the retinal surface. (E) Rup-
ture of the ILM (arrow). (F) GFAP
immunohistochemistry showing ir-
regularities of the retinal surface and
numerous positive cells over the ret-
ina and in the vitreous (arrows). (G)
ED1 immunohistochemistry showing
numerous positive cells in the vit-
reous and over the retina. (H) Pan-
cytokeratin immunohistochemistry
showing no positive cells labeled in
the vitreous or over the retina and a
thick staining of the resident RPE
layer. Magnification, (A) 3165; (B)
3350.
3920 Behar–Cohen et al. IOVS, November 2000, Vol. 41, No. 12
role in the development of PVR: the number of cells in the
vitreous cavity, the cell types, the interaction between cells
located in the vitreous and the resident retinal cells, the pres-
ence of diffusible mediators, and a blood–ocular barrier break-
down. In experimental models of retinal detachments, all non-
neuronal cell types of the detached and the nondetached retina
proliferate at a maximal rate 3 to 4 days after the onset of the
detachment.28 Whether the proliferative messages originate
from the detached retina, the RPE, the dislocated retinal cells in
the vitreous, or the inflammatory cells or in relation to the
blood–ocular barrier breakdown29 is not known.
Our results show that the injection of RMG cells into the
vitreous of LPS-stimulated rats, alone or in combination with
RPE cells, induces the formation of glial tissue at the retinal
surface, which is responsible for localized retinal detachments.
EIU is a self-limited inflammation of both segments of the
eye in which the cytokines expressed in the eye tissues and
media are very similar to those detected in animal models of
PVR and in human PVR.9,11,15,18 Moreover, an activation of
retinal cells by the systemic injection of LPS is observed as is
the case when the retina is detached.3,4,5,28–32 The syngeneic
retinal cells injected into the vitreous cavity of rat eyes with
EIU were thus in a biologic environment that was close to that
of the early phase of retinal detachment.
EIU clearly increased the density of membranes induced
by the injection of retinal cells, which could be related to an
activation of the resident RMG cells that increases their poten-
tial to proliferate and synthesize an extracellular matrix. In-
deed, although no labeling was detected in normal control
retina, in rats with EIU alone or combined with the injection of
saline in the vitreous, positive GFAP staining of resident RMG
cells was observed up to 16 days after LPS injection (not
shown), but no membrane formation ws observed. It is not
clear whether the proliferating membranes originated from the
injected cells or from an activation of RMG resident cells. But,
the activation of the RMG cells of the whole retina, the irreg-
ularities of the end feet of the Mu¨ller cells at the ILM, and the
presence of numerous astrocytes in this region are arguments
in favor of this latest hypothesis. Whether cells present in the
PVR membranes could at least partially originate from migrat-
ing retinal glial cells is another possibility. Indeed, systemic
injection of LPS has been shown to induce a massive invasion
of the retina by OX421macrophage–microglial cells, which
decreases from 72 hours to return to normal at 14 days.33 In
contrast, in EIU-affected rats with proliferative membranes, a
cellular inflammation is still observed 14 to 15 days after LPS-
injection, which indicates a long-lasting inflammatory process.
Inflammation induced by EIU enhanced the proliferative pro-
cess that in return enhanced and prolonged ocular cell infiltra-
tion.
The first event that was observed after RMG or RPE1RMG
injections, at day 5, was disruption and irregularities of the
FIGURE 5. Immunohistochemistry 15
days after systemic LPS injection and
saline intravitreal injection. Ciliary
body: (A) ED1 and (B) OX-42 stain-
ing. Very few ED1- and OX42-posi-
tive cells were still present in the
iris–ciliary body at 15 days after LPS
injection. Retina: (C) GFAP staining,
showing activated RMG cells; (D)
VIM staining; (E) OX-42 staining,
showing microglia in the retina but
no 0X-42-positive infiltrating cells;
and (F) pancytokeratin staining of
the resident RPE cells.
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ILM, disorganization of RMG cell end feet, in addition to in-
traretinal GFAP labeling, followed by the formation of GFAP
and VIM-positive tissue, leading to tractional detachments. It
has been shown recently that RMG cells injected in the rabbit
vitreous induce antigenic changes of RMG into the retina itself,
leading to the expression of contractile protein. Dislocated
RMG cells could therefore participate in the activation of in-
traretinal RMG cells.34 It is of interest that RPE was the less
potent cell type for the induction of a preretinal or intraretinal
proliferation. This could be explained by the relatively low
amount of injected cells, because the proliferative critical mass
of cells for the rabbit PVR is 250,000,35,36 but no critical mass
has been determined for the rat; by rapid death of RPE cells as
soon as 5 days after injection, as shown by the absence of
proliferative RPE cells in early cellular membranes, or in the
vitreous. TGF-b, which is expressed during EIU, has been
shown to have a proapoptotic effect on cultured RPE cells in
vitro, whereas no apoptosis could be detected in glial cells.37
This suggests that in our experimental conditions, apoptosis of
the injected retinal cells could occur early after their intravit-
real injection, whereas glial proliferation from the activated
resident RMG cells would persist for longer periods. This
hypothesis is currently under examination. However, RPE
cells, present early, seem to play the role of starter in the
proliferative process, because the coinjection of RMG1RPE
was more potent than RMG cells alone. The synthesis of cyto-
kines by RPE cells and the release of growth factor by the dying
cells could be involved in this starter effect. Retinal cells in
contact with the vitreous show strong phenotypic changes,38
and stimulated RPE and glial cells themselves synthesize cyto-
kines that act in an autocrine, paracrine, or intracrine manner.
In return, after RMG cell injection, the RPE layer from the host
retina was much thicker, as shown by cytokeratin labeling,
even in the absence of retinal detachment. This was further
confirmed by the presence of RPE cells in the retinal folds.
The type of proliferation observed in our model was
similar to that induced in the rabbit by RMG cell intravitreal
injection39 and by dispase intravitreal injection.40 The prepap-
illary injection of dispase allowed the formation of proliferative
retinopathy with retinal folds and localized traction retinal
detachment, which are thought to originate from activation of
native cells.40 However, total retinal detachments did not oc-
cur as in other experimental models of PVR that have been
developed in the rabbit using injections of heterologous cells
or homologous fibroblasts.41–44 Those models efficiently in-
duce total tractional retinal detachment and could be very
effective for therapeutic screening, but they may have a very
different pathogenesis than human PVR.
In conclusion, in our experiments EIU enhanced vitreo-
retinopathy induced by the injection of syngeneic retinal cells
FIGURE 6. Immunohistochemistry 15
days after systemic LPS injection and
RPE1RMG intravitreal injection. Cil-
iary body: (A) ED1 and (B) OX-42
staining showed numerous infiltrat-
ing cells still present in the anterior
segment at 15 days after LPS and cell
injections. Retina: (C) GFAP staining
showing a disorganized inner retina
and glial proliferation at the retinal
surface; (D) VIM staining of the neo-
formed tissue; (E) OX-42 labeling of
the microglia but showing no infil-
trating cells; and (F) pancytokeratin,
staining showing a thick RPE layer in
a proliferative state, as was shown by
anti-cytokeratin 18 labeling (not
shown).
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in the vitreous cavity. Correlatively, the injection of retinal cells
increased clinical inflammation and cytokine expression in the
iris–ciliary body and in the retina, which is also correlated to
development of vitreoretinopathy. This PVR model in the rat
could be of use in further study of cellular interactions in the
vitreous and between the vitreous and the retina and particu-
larly study of the early events occurring at the vitreoretinal
interface.
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